Related Experiment Video
Updated: Jul 18, 2026

Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes
Published on: October 3, 2019
Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors
Artem G Evdokimov1, Matthew Pokross, Richard L Walter
1Structural Biology Core Facility, The Procter & Gamble Pharmaceuticals, Mason, Ohio 45040, USA. artem@xtals.org
Abstract:
In this article we describe the application of structural biology methods to the discovery of novel potent inhibitors of methionine aminopeptidases. These enzymes are employed by the cells to cleave the N-terminal methionine from nascent peptides and proteins. As this is one of the critical steps in protein maturation, it is very likely that inhibitors of these enzymes may prove useful as novel antibacterial agents. Involvement of crystallography at the very early stages of the inhibitor design process resulted in serendipitous discovery of a new inhibitor class, the pyrazole-diamines. Atomic-resolution structures of several inhibitors bound to the enzyme illuminate a new mode of inhibitor binding.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Antibiotic Selection
Clinical Significance of Antibiotic Resistance

